×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Atlas Venture Fund XI, L.P.

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 26, 2024Sale$23.72201,0954,769,0966,216,250Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 26, 2024Sale$23.7247,1241,117,5771,564,932Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 27, 2024Sale$24.41298,7027,290,0885,878,544Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 27, 2024Sale$24.4169,9971,708,3381,514,874Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 28, 2024Sale$24.84154,6743,841,5765,700,521Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 28, 2024Sale$24.8436,246900,2281,488,486Feb 28, 2024, 07:13 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 21, 2024Sale$22.57184,5014,164,8176,666,628Feb 23, 2024, 06:58 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 22, 2024Sale$22.66119,3602,704,6986,512,104Feb 23, 2024, 06:58 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 23, 2024Sale$22.70159,5423,621,6046,352,562Feb 23, 2024, 06:58 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 23, 2024Sale$22.7037,386848,6621,585,137Feb 23, 2024, 06:58 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 20, 2024Sale$22.72169,5393,852,6526,819,475Feb 20, 2024, 06:35 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 15, 2024Sale$23.89177,9064,249,6007,150,324Feb 20, 2024, 06:35 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 16, 2024Sale$23.14162,7073,765,0406,985,504Feb 20, 2024, 06:35 PM
XLOXilio Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 08, 2024Sale$0.647334692,019,563Feb 09, 2024, 04:33 PM
XLOXilio Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerFeb 08, 2024Sale$0.64267171734,546Feb 09, 2024, 04:33 PM
XLOXilio Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerJan 12, 2024Sale$0.83560465734,813Jan 16, 2024, 06:16 PM
XLOXilio Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerJan 11, 2024Sale$0.871,5661,3622,021,836Jan 16, 2024, 06:16 PM
XLOXilio Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerJan 11, 2024Sale$0.87569495735,373Jan 16, 2024, 06:16 PM
XLOXilio Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerJan 12, 2024Sale$0.831,5401,2782,020,296Jan 16, 2024, 06:16 PM
DYNDyne Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerDec 12, 2022Buy$10.70934,58110,000,017934,581Dec 14, 2022, 04:55 PM
THRDThird Harmonic Bio, Inc.Atlas Venture Fund XI, L.P.10% OwnerSep 19, 2022Buy$17.00300,0005,100,00010,313,763Sep 19, 2022, 04:51 PM
DAWNDay One Biopharmaceuticals, Inc.Atlas Venture Fund XI, L.P.10% OwnerJun 17, 2022Buy$15.00766,66711,500,005766,667Jun 22, 2022, 05:09 PM
IKNAIkena Oncology, Inc.Atlas Venture Fund XI, L.P.10% OwnerMar 30, 2021Buy$16.00125,0002,000,000874,634Dec 14, 2021, 08:27 PM
IKNAIkena Oncology, Inc.Atlas Venture Fund XI, L.P.10% OwnerDec 10, 2021Sale$15.0311,989180,1951,256,224Dec 14, 2021, 08:27 PM
IKNAIkena Oncology, Inc.Atlas Venture Fund XI, L.P.10% OwnerDec 13, 2021Sale$14.648,330121,9511,247,894Dec 14, 2021, 08:27 PM
IKNAIkena Oncology, Inc.Atlas Venture Fund XI, L.P.10% OwnerDec 14, 2021Sale$14.005,95983,4261,241,935Dec 14, 2021, 08:27 PM
XLOXilio Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerOct 26, 2021Buy$16.00187,5003,000,000735,942Oct 26, 2021, 05:01 PM
AKROAkero Therapeutics, Inc.Atlas Venture Fund XI, L.P.10% OwnerJun 24, 2019Buy$16.00270,0004,320,000505,099Jun 25, 2019, 06:06 PM